"Understanding that certain patients are at greater risk for MCI or Parkinson's disease will allow for early intervention, which is vital in the case of such disorders that destroy brain cells. Although we are still searching for effective treatments, our best chance of success is to identify and treat these disorders early, before cell death."
1. A neurologic syndrome usually resulting from deficiency of the neurotransmitter dopamine as the consequence of degenerative, vascular, or inflammatory changes in the basal ganglia; characterized by rhythmic muscular tremors, rigidity of movement, festination, droopy posture, and masklike facies.
2. A syndrome similar to parkinsonism. Some features seen with Parkinson's disease that occur with other disorders (progressive supranuclear palsy) or as a side effect of certain medications (antipsychotic drugs).
Disclaimer: This informational section on Medical News Today is regularly reviewed and updated, and provided for general information purposes only. The materials contained within this guide do not constitute medical or pharmaceutical advice, which should be sought from qualified medical and pharmaceutical advisers.
© MediLexicon International Ltd
This page was printed from: http://www.medicalnewstoday.com/info/parkinsons-disease
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2017 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.